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ABSTRACT
Background: Some observational studies have shown a beneficial
effect of dairy consumption on blood pressure, especially in over-
weight and relatively young (40 y) persons. However, no results
from prospective studies conducted in a free-living population exist
that show this association in middle-aged adults.
Objective: The aim of the present study was to assess whether total,
low-fat, and whole-fat dairy consumption was associated prospec-
tively with the risk of hypertension.
Design: This was a prospective study conducted in 5880 university
graduates in Spain, aged20 y in 2000 (x age: 37 y), free of hyper-
tension and cardiovascular disease at baseline, and followed-up with
mailed questionnaires for a median of 27 mo. Dairy consumption
was assessed with a previously validated semiquantitative food-
frequency questionnaire.
Results: One hundred eighty new cases of hypertension were iden-
tified. The hazard ratio of hypertension between extreme quintiles of
low-fat dairy product consumption was 0.46 (95% CI: 0.26, 0.84;
P for trend 0.02) after adjustment for the main known risk factors
for hypertension and several dietary factors. No significant associ-
ation between whole-fat dairy products or total calcium intake and
incident hypertension was seen.
Conclusion: In this Mediterranean cohort, low-fat dairy consump-
tion, but not whole-fat dairy consumption, was associated with a
lower risk of incident hypertension. Am J Clin Nutr 2005;82:
972–9.
KEY WORDS Milk, Dietary Approaches to Stop Hyperten-
sion diet, high blood pressure, calcium, Mediterranean diet, Spain
INTRODUCTION
Diet has an important role in the primary prevention of hyper-
tension (1). The Dietary Approaches to Stop Hypertension
(DASH) trial has shown that a dietary pattern rich in fruit, veg-
etables, and low-fat dairy products and with reduced total and
saturated fat (the DASH diet) can be effective in the prevention
of hypertension (2, 3). This pattern was more effective than was
a diet rich in fruit and vegetables in which dairy consumption was
low. However, the DASH study was conducted in a controlled
setting with a short follow-up (8 wk), and it was not specifically
designed to assess the individual effects of each element of the
protective dietary pattern.
Nonetheless, substantial epidemiologic and clinical data exist
that show that a long-term high consumption of fruit and vege-
tables, one of the main components of the DASH diet, is inversely
associated with blood pressure (BP) levels independent of other
dietary factors (4–7). However, the relation between dairy con-
sumption, another important building block of the DASH diet,
and BP is not so clear. Some prospective studies have found a
beneficial relation between dairy consumption and the incidence
of hypertension or a change in BP, but this association was only
evidenced in young adults (8) and in children (9). On the other
hand, dairy consumption has been associated with a higher car-
diovascular disease mortality risk in postmenopausal women
(10), whereas the nutritional intervention in the Oslo study,
which was mainly focused on reducing whole-fat dairy con-
sumption, was associated with a lower risk of coronary events
(11). In addition to this apparent inconsistency in epidemiologic
results, no prospective studies have assessed the relation between
dairy consumption and the incidence of hypertension in persons
in Mediterranean countries where intake of fat, particularly
monounsaturated fatty acids, is high and where, perhaps, results
from the DASH trial could not be directly applied (12). The
objective of the present study was to prospectively assess the
potential association between dairy consumption, particularly
low-fat dairy products, and the risk of hypertension in a Medi-
terranean population.
SUBJECTS AND METHODS
Study population
The University of Navarra Follow-up Study (Seguimiento
Universidad de Navarra) is composed of a dynamic cohort of
university graduates. A detailed description of the study methods
was published elsewhere (13). Briefly, beginning in December
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1999, all former students of the University of Navarra, registered
nurses from some Spanish provinces, and university graduates
from other associations received a mailed questionnaire and a
letter of invitation to participate in the Seguimiento Universidad
de Navarra Study. From December 1999 to January 2002, 9907
of them answered the questionnaire. Subsequently, the follow-up
of initial responders was made through biennial mailed question-
naires; persons who did not reply were sent5 additional mail-
ings. On 25 July 2004, 8646 (87%) of the participants had an-
swered the first follow-up questionnaire. The participants were
aged between 20 and 90 y at baseline. The Institutional Review
Board of the University of Navarra approved the study protocol.
Participants were excluded at baseline if they reported a his-
tory of cardiovascular disease, cancer, or diabetes or if they had
prevalent hypertension. Participants with extreme total energy
intakes (400 or3500 kcal/d for women and600 or4200
kcal/d for men) or those who had missing values for any of the
variables that were included in the analyses were also excluded.
Of the initial 9907 persons who responded to the baseline ques-
tionnaire, 1045 were excluded because they had hypertension;
813 because they had previous cardiovascular disease, cancer, or
diabetes; 1018 because they had extreme energy intakes; and 784
because they had missing values for a covariate. Some partici-
pants were included in more than one of these categories. This
left 6686 participants available for the baseline analyses.
Dietary assessment
The baseline questionnaire included a semiquantitative food-
frequency questionnaire that was previously validated in Spain,
with 136 items and open-label questions for information about
use of dietary supplements (14). The questionnaire was based on
typical portion sizes and had 9 options for the frequency of intake
in the previous year for each food item (ranging from never or
almost never to6 times/d). Dairy consumption was assessed in
15 of these items (whole-fat milk, partially skim milk, skim milk,
condensed milk, whipped cream, yogurt, skim yogurt, milk-
shake, cottage cheese or junket, petit Suisse cheese, spreadable
cheese wedges, soft unripened cheese, other cheese, custard, and
ice cream). Skim and partially skim milk were the major con-
tributors to low-fat dairy consumption and accounted for 92% of
the total low-fat dairy consumption. The follow-up questionnaire
included some questions about changes in the participant’s ha-
bitual diet. A dietitian updated the nutrient data bank using the
latest available information that was included in the food-
composition tables for Spain (15, 16).
Assessment of other covariates
Information about the main known risk factors for hyperten-
sion was reported in baseline questionnaires. Body mass index
(BMI), defined as weight (in kg) divided by height2 (in m), was
ascertained in the baseline questionnaire. The validity of self-
reported weight was assessed in a subsample of the cohort (n
144). The mean relative error in self-reported weight was 1%.
The correlation coefficient (r) between measured and self-
reported weight was 0.99 (95% CI: 0.98, 0.99) (17). We calcu-
lated an activity metabolic equivalent (MET) index for each
participant to quantify the volume and intensity of leisure-time
physical activity as previously described (18). We assessed each
participant’s involvement and time spent in 17 different activi-
ties. We assigned a multiple of the resting metabolic rate (MET
score) to each of these activities using previously published
guidelines to quantify the average intensity of physical activity
(18). The MET index of each activity was multiplied by the
weekly time spent in each activity and a value of overall weekly
MET-hours was obtained. In the validation study (19), a signif-
icant correlation between objectively measured physical activity
with an accelerometer and the overall weekly MET-hours as-
sessed with our questionnaire was observed (r  0.51, P 
0.001). Information about any previous diagnosis of cardiovas-
cular disease, cancer, diabetes, hypercholesterolemia, or other
conditions and the participant’s family history of hypertension
was also obtained in the baseline questionnaire.
Hypertension ascertainment
The participants reported whether they had received a medical
diagnosis of hypertension in the baseline and follow-up ques-
tionnaires. Additionally, the most recent systolic and diastolic
BP values were reported in the baseline questionnaire. The date
of hypertension diagnosis (if applicable) and BP measurements
in the time elapsed since the baseline questionnaire were also
reported in follow-up questionnaires.
A participant was considered to have hypertension at baseline
if they reported a medical diagnosis of hypertension, were re-
ceiving antihypertensive medication, or reported a systolic BP
140 mm Hg or a diastolic BP90 mm Hg (20). New cases of
hypertension were defined as those participants who reported a
physician diagnosis of hypertension in the follow-up question-
naire and did not have hypertension at baseline.
A validation study that was conducted in a random sample of
participants (n  127) in the metropolitan area of Pamplona
(Navarra, Spain) showed an adequate validity of the self-reported
diagnosis of hypertension in this highly educated cohort (positive
predictive value: 82%; negative predictive value: 85%) when a
repeated direct measured value of BP was used as the gold stan-
dard. When the cutoff for hypertension in the validation study
was set at 160/95 mm Hg instead of 140/90 mm Hg, the negative
predictive value of self-reporting was 98% instead of 85%, which
suggests that the participants that were considered to have false-
negative results in the validation study had BP values near the
cutoff.
Statistical analysis
Food and nutrient intakes were adjusted for total energy intake
with the residuals method, and separate regression models were
performed to obtain the residuals for women and men (21).
Energy-adjusted food or nutrient intakes were categorized in
quintiles. For each participant, we computed person-time of
follow-up from the date the baseline questionnaire was returned
to the date the follow-up questionnaire was returned or to the date
of a new hypertension diagnosis.
Analyses were performed with SPSS version 11.0 (SPSS Inc,
Chicago, IL). Hazard ratios (HRs) and their 95% CIs were esti-
mated with Cox proportional hazards models, with adjustment
for potential confounders. An initial model included only age and
sex as covariates. We then included universally accepted risk
factors for hypertension (physical activity, BMI, and alcohol and
sodium intakes) and variables closely associated with lifestyle
and health-related habits (smoking and a history of hypercholes-
terolemia) in a first multivariate model. Finally, to assess the
possibility of confounding by other dietary variables, we ran
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another multivariate model (multivariate 2), which added several
dietary factors that have been related to the risk of hypertension
in some studies. In all analyses, the reference group was the
lowest intake category. Multivariable tests for linear trends were
conducted by assigning the median value to each quintile and
modeling these values as a continuous variable. To investigate
whether age, sex, or BMI modified the association between dairy
consumption and the incidence of hypertension, we used the
log-likelihood ratio test to assess statistical interaction with a
multiplicative term for dairy consumption and the potentially
modifying variable in the models. All P values are 2-tailed.
Statistical significance was set at P 0.05.
RESULTS
From the 6686 participants who met the inclusion criteria,
5880 (88%) answered the 2-y follow-up questionnaire. In the
baseline comparison, nonresponders were more likely to be
young and to have a higher intake of low-fat dairy products than
were responders; however, other characteristics were similar.
The characteristics of the participants are shown in Table 1
and Table 2 according to the consumption of total dairy products
and low-fat dairy products. Women, physically active partici-
pants, and younger persons had a higher total dairy and low-fat
dairy consumption. Additionally, low-fat dairy consumption was
directly associated with fruit and vegetable consumption and
with potassium and fiber intake and was inversely associated
with alcohol and saturated fatty acid intake. In this population, fat
intake accounted for 37% of total energy intake in men and 38%
in women.
We observed a significant reduction in the risk of hypertension
in the participants in the fourth quintile of dairy consumption
when compared with the participants in the lowest quintile, but
the inverse linear trend was not consistent (Table 3). However,
when we separately assessed the effect of low-fat and whole-fat
dairy product consumption, we found a 50% reduction in the
incidence of hypertension in the participants with the highest
consumption compared with the participants with the lowest
consumption of low-fat dairy products after adjustment for the
main known risk factors of hypertension (multivariate-adjusted
HR: 0.44; 95% CI: 0.25, 0.77) and a significant trend that sug-
gested a dose-response relation. This association did not sub-
stantially change when we made additional adjustments for other
dietary factors (multivariate model 2 in Table 3). In contrast, no
clear trend in the association between whole-fat dairy intake and
the risk of hypertension was observed. An additional adjustment
for total calcium intake did not significantly affect the HR esti-
mates for low-fat dairy products (adjusted HR: 0.38; 95% CI:
0.19, 0.74, in a comparison of the fifth quintile with the lowest
quintile of low-fat dairy intake; P for trend  0.01, data not
shown). Additional adjustment for protein intake, phosphorus
intake, or total fat intake did not significantly affect our estimates
(data not shown).
Calcium from low-fat dairy products, but not total calcium
intake or calcium from whole-fat dairy products, was associated
TABLE 1
Distribution of potential confounding variables across quintiles of total dairy product consumption1
Quintile
P for trend1 (n 1177) 2 (n 1174) 3 (n 1177) 4 (n 1176) 5 (n 1176)
Dairy consumption (g/d) 155.6 75.32 292.4 27.6 385.9 29.7 530.0 53.0 798.8 215.4
Whole-fat dairy (g/d) 108.4 84.9 185.9 102.2 237.7 122.0 281.2 208.9 324.4 293.4
Low-fat dairy (g/d) 47.2 71.7 106.5 101.2 148.2 121.5 248.7 212.8 474.3 337.7
Age (y) 36.9 11.1 36.0 10.7 35.7 10.6 35.4 10.6 34.7 10.8  0.001
Sex (% females) 56.7 58.5 57.3 65.2 68.8  0.001
BMI (kg/m2) 23.2 3.5 23.2 3.3 23.3 3.3 22.9 3.2 22.9 3.1 0.01
Physical activity (MET-hours/wk) 15.8 20.0 15.7 18.6 17.4 22.1 17.2 22.0 17.9 21.5  0.001
Smokers (%)  0.001
Past 26.2 25.5 26.6 23.3 23.6
Current 31.4 28.0 26.2 25.9 26.2
Hypercholesterolemia (%) 13.7 12.5 12.3 11.8 13.9 0.96
Total energy intake (kcal/d) 2553 689 2381 597 2204 590 2463 636 2402 604  0.001
Alcohol intake (g/d) 8.7 13.5 6.9 9.0 5.8 8.3 5.2 7.6 4.1 6.3  0.001
Sodium intake (g/d) 4.2 3.7 4.2 2.2 4.1 2.0 4.0 2.0 3.9 1.8  0.001
Potassium intake (g/d) 4.5 1.4 4.6 1.1 4.6 1.1 4.7 1.1 5.0 1.2  0.001
Calcium intake (g/d) 0.9 0.2 1.0 0.2 1.2 0.2 1.4 0.3 1.7 0.4  0.001
Magnesium intake (mg/d) 400.0 92.6 400.1 78.1 405.0 73.4 408.7 76.4 435 79.0  0.001
Phosphorus intake (g/d) 1.7 0.3 1.8 0.3 1.9 0.3 2.0 0.3 2.3 0.4  0.001
Total fat (% of energy intake) 37.4 7.4 37.8 6.3 37.3 6.0 37.7 6.3 36.2 6.4  0.001
SFA (% of energy intake) 12.0 3.1 12.8 2.8 13.0 2.9 13.2 3.1 13.2 3.7  0.001
MUFA (% of energy intake) 16.7 4.4 16.4 3.6 15.9 3.3 16.0 3.6 15.1 3.4  0.001
Total protein intake (g/d) 99.3 19.2 103.5 16.4 105.4 13.9 107.3 15.5 114.6 18.1  0.001
Fiber intake (g/d) 28.5 12.2 26.7 9.7 26.5 9.2 26.0 9.6 26.0 10.0  0.001
Caffeine intake (mg/d) 44.0 43.4 43.9 39.1 42.5 37.0 44.2 38.6 48.8 44.4 0.008
Vegetable consumption (g/d) 521.9 347.4 504.4 290.1 496.7 277.7 508.9 286.0 517.5 310.9 0.88
Fruit consumption (g/d) 339.4 348.1 309.4 245.9 326.0 258.6 306.6 243.2 334.1 263.0 0.57
1 MET, metabolic equivalent; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids.
2 x  SD (all such values).
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with a lower risk of hypertension (Table 4). Neither total vitamin
D nor lactose intake was significantly associated with the risk of
hypertension (data not shown). Low-fat dairy products ac-
counted for 39% of the calcium intake in our cohort. Whole-fat
dairy products contributed 26% and nondairy sources contrib-
uted 35% to the total calcium intake.
When we restricted the analysis to the participants who re-
ported a BP measurement in the period between the baseline and
first follow-up questionnaire or when we excluded participants
with hypercholesterolemia, the results were not significantly
changed (data not shown). These results did not vary signifi-
cantly by sex, BMI (25 and25), age (40 and40 y), total
fat or protein intake, or the ratio of calcium to phosphorus in the
diet.
DISCUSSION
In this highly educated Mediterranean cohort, low-fat dairy
intake was associated with a lower risk of incident hypertension,
even after control for several potential confounders such as age,
sex, physical activity, BMI, and major dietary factors related to
hypertension. This association was not statistically different be-
tween men and women, younger and older persons, and lean and
obese persons.
The observed risk reduction was high. Two reasons, however,
support that a substantial protective association actually exists.
First, the reported results are consistent with the findings of the
Coronary Artery Risk Development in Young Adults Study (8)
and with findings of clinical trials that included low-fat dairy
products in the intervention diet (2, 22). For instance, in the
DASH trial (2), systolic and diastolic BP reductions were5.5
and 3.0 mm Hg, respectively, for the combination (DASH)
diet, whereas respective decreases of only2.8 and1.1 mm Hg
were observed with the fruit-and-vegetables diet. These results
also represent an important difference in the magnitude of the
effect of each diet, which had clear-cut differences in the amount
of low-fat dairy products provided (2.0 servings/d in the combi-
nation diet compared with 0 servings/d in the fruit-and-
vegetables diet). Second, our cohort provided a unique opportu-
nity to capture an impressive between-subject variability in the
consumption of low-fat dairy products, which ranged from 3 g/d
in the lowest quintile to 615 g/d in the top quintile; a large
between-subject variation in the consumption of a nutrient or
food within a cohort results in a better ability to ascertain diet-
disease associations and to obtain stronger estimates for the rel-
ative risk.
To our knowledge, this is the first study that showed an inverse
association between the consumption of low-fat dairy products
and incident hypertension independent of other dietary factors in
a prospectively followed-up population, which included subjects
aged 40 y. Nonetheless, previous epidemiologic studies have
assessed the relation between dairy consumption and BP or hy-
pertension. Thus, some cross-sectional studies have shown a
beneficial association between dairy consumption and BP (7, 23).
Also,2prospectivestudies reportedanindependentbeneficialeffect
of dairy consumption on BP, but they were conducted in either
young adults or children. One of the studies, the Coronary Artery
Risk Development in Young Adults Study, followed up3000
persons aged 18-30 y in the United States for 10 y (8). In that
TABLE 2
Distribution of potential confounding variables across quintiles of low-fat dairy product consumption1
Quintile
P for trend1 (n 1176) 2 (n 1176) 3 (n 1177) 4 (n 1175) 5 (n 1176)
Low-fat dairy consumption (g/d) 2.5 4.62 11.3 14.6 140.5 60.8 255.9 55.7 614.7 206.5
Age (y) 34.6 9.9 36.7 11.0 35.6 10.7 36.3 10.9 35.6 11.2 0.14
Sex (% females) 50.8 49.7 64.0 66.7 75.3  0.001
BMI (kg/m2) 22.8 3.3 23.4 3.5 23.2 3.3 23.3 3.2 22.9 3.1 0.67
Physical activity (MET-hours/wk) 16.5 19.6 15.7 20.3 16.4 21.2 17.3 21.5 18.1 21.8 0.01
Smokers (%) 0.16
Past 23.0 25.3 25.1 26.6 25.3
Current 27.4 27.3 28.0 28.7 26.3
Hypercholesterolemia (%) 6.6 12.8 13.3 16.3 15.2  0.001
Total energy intake (kcal/d) 2903 448 2078 557 2408 672 2149 549 2466 573  0.001
Alcohol intake (g/d) 7.4 11.6 6.3 9.3 6.9 10.1 5.8 7.9 4.6 7.4  0.001
Sodium intake (g/d) 4.2 2.6 4.2 2.2 4.0 1.9 4.2 3.4 3.9 1.8 0.03
Potassium intake (g/d) 4.3 1.1 4.5 1.0 4.6 1.1 4.9 1.1 5.2 1.2  0.001
Calcium intake (g/d) 1.0 0.4 1.1 0.3 1.1 0.3 1.3 0.3 1.6 0.4  0.001
Magnesium intake (mg/d) 381.2 79.5 396.6 71.0 404.1 79.2 423.9 76.0 443.7 85.0  0.001
Phosphorus intake (g/d) 1.8 0.3 1.8 0.3 1.8 0.3 2.0 0.3 2.2 0.4  0.001
Total fat (% of energy intake) 38.5 5.9 38.6 6.8 37.5 6.6 36.7 6.3 35.1 6.3  0.001
SFA (% of energy intake) 13.5 2.9 13.7 3.4 12.6 3.1 12.4 3.0 11.9 3.0  0.001
MUFA (% of energy intake) 16.4 3.3 16.5 4.0 16.3 3.9 15.8 3.6 15.0 3.6  0.001
Total protein intake (g/d) 101.1 17.7 103.6 16.0 103.4 18.1 108.5 15.6 113.5 17.0  0.001
Fiber intake (g/d) 24.2 10.5 26.0 9.4 26.9 10.5 28.5 9.4 28.2 10.7  0.001
Caffeine intake (mg/d) 43.5 41.4 41.3 38.3 44.7 41.7 43.3 35.9 50.7 44.9  0.001
Vegetable consumption (g/d) 444.1 308.4 481.7 276.5 506.3 292.0 562.7 294.8 554.7 327.4  0.001
Fruit consumption (g/d) 260.1 264.4 300.6 242.6 330.1 299.3 358.0 258.6 365.6 291.4  0.001
1 MET, metabolic equivalent; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids.
2 x  SD (all such values).
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population, total dairy consumption (including both whole and
low-fat products) was significantly associated with a lower risk
of hypertension only in obese subjects but not in normal-weight
subjects, although the trend in subjects with a BMI  25 was
marginally significant (P0.06) and suggests a protective effect
in that group also. However, that study did not evaluate this
question in persons aged 30 y, in whom the incidence of hy-
pertension is much higher and preventive efforts are more
needed. Similarly, in the Framingham Children’s Study, children
who consumed 2 servings/d of dairy products during their
preschool years had smaller increments in systolic BP during
childhood, but the association with diastolic BP was not clear (9).
Calcium could partly account for the observed inverse asso-
ciation between dairy consumption and the risk of hypertension.
However, calcium intake has only a small effect on BP and
cannot fully explain the important reduction in hypertension risk
that was observed (24). In fact, studies that assessed the relation
between calcium intake and coronary artery disease or stroke,
which are 2 major consequences of hypertension, could not find
any association (25) or the association was present only for cal-
cium from dairy products but not from other sources (26, 27). In
our study, several facts suggest an effect of low-fat dairy products
beyond their calcium content. First, only calcium from low-fat
dairy products was associated with a lower risk of hypertension.
Second, although a high protein intake, an optimal dietary phos-
phorus to calcium balance, and a relatively high fat intake all
improve calcium absorption (25, 26), stratified analyses for these
factors did not show clear evidence of a modification in the
relation between calcium and hypertension. Finally, when we
adjusted for total calcium intake, the risk estimates for the asso-
ciation between low-fat dairy products and hypertension did not
materially change, which suggests that calcium is not the only
nutrient responsible for this inverse association.
Adjustment for other dietary factors such as potassium, mag-
nesium, phosphorus, protein, or total fat did not significantly
modify the results. It could be that other components that occur
in low-fat dairy products or an interaction between some differ-
ent nutrients may have caused the observed reduction in the risk
of hypertension. For example, milk proteins—both caseins and
whey proteins—are a rich source of angiotensin converting en-
zyme inhibitory peptides. In animal models, these proteins (ca-
sokinins and lactokinins) have been shown to significantly re-
duce blood pressure (28).
Although no definitive explanation exists for the inverse as-
sociation found for only low-fat dairy products and not for full-
fat dairy products, it is plausible that saturated fats in whole-fat
dairy products somehow neutralize the beneficial effect of dairy
consumption. The capacity of calcium to form soaps is much
higher when fat intake is increased. Therefore, foods that are high
in fat, such as whole-fat dairy foods, might hinder calcium ab-
sorption, thereby reducing the bioavalability of calcium (29, 30).
This interpretation has some support from epidemiologic stud-
ies; for example, although dairy consumption reduced the inci-
dence of the metabolic syndrome in the Coronary Artery Risk
Development in Young Adults Study, the consumption of whole-
fat dairy products was associated with an increase in LDL cho-
lesterol. This association was not observed for low-fat dairy
products (31). Low-fat, but not whole-fat, dairy consumption
TABLE 3
Hazard ratios (HRs) and 95% CIs of hypertension according to quintiles of dairy product consumption in the Seguimiento Universidad de Navarra cohort
Quintile
P for trend1 2 3 4 5
Total dairy consumption
New cases of hypertension 49 38 39 24 30
Person-years 2709.3 2708.3 2708.5 2705.4 2694.4
Incidence (cases per 1000 person-years) 18.1 14.0 14.4 8.9 11.1
Age- and sex-adjusted HR (95% CI) 1 0.85 (0.56, 1.30) 0.89 (0.58, 1.35) 0.59 (0.36, 0.97) 0.79 (0.50, 1.25) 0.14
Multivariate 1 HR (95% CI)1 1 0.85 (0.55, 1.29) 0.84 (0.54, 1.29) 0.58 (0.35, 0.95) 0.75 (0.47, 1.20) 0.10
Multivariate 2 HR (95% CI)2 1 0.84 (0.54, 1.29) 0.85 (0.54, 1.32) 0.57 (0.34, 0.95) 0.75 (0.45, 1.27) 0.12
Low-fat dairy consumption
New cases of hypertension 40 45 35 39 21
Person-years 2735.1 2706.1 2722.9 2657.7 2704.2
Incidence (cases per 1000 person-years) 14.6 16.6 12.9 14.7 7.8
Age- and sex-adjusted HR (95% CI) 1 0.94 (0.62, 1.45) 0.84 (0.53, 1.33) 0.96 (0.62, 1.50) 0.55 (0.32, 0.94) 0.03
Multivariate 1 HR (95% CI)1 1 0.76 (0.47, 1.23) 0.65 (0.41, 1.06) 0.74 (0.45, 1.21) 0.44 (0.25, 0.77) 0.009
Multivariate 2 HR (95% CI)2 1 0.77 (0.47, 1.27) 0.65 (0.40, 1.06) 0.77 (0.46, 1.28) 0.46 (0.26, 0.84) 0.02
Whole-fat dairy consumption
New cases of hypertension 30 25 54 40 31
Person-years 2710.0 2696.0 2680.9 2712.5 2726.5
Incidence (cases per 1000 person-years) 11.1 9.3 20.1 14.7 11.4
Age- and sex-adjusted HR (95% CI) 1 0.92 (0.54, 1.57) 1.88 (1.20, 2.94) 1.42 (0.88, 2.30) 1.21 (0.73, 2.01) 0.48
Multivariate 1 HR (95% CI)1 1 0.96 (0.56, 1.67) 1.99 (1.23, 3.20) 1.52 (0.92, 2.51) 1.35 (0.80, 2.27) 0.30
Multivariate 2 HR (95% CI)2 1 1.02 (0.58, 1.77) 1.98 (1.20, 3.25) 1.48 (0.88, 2.51) 1.37 (0.77, 2.42) 0.44
1 Cox regression model adjusted for age (continuous variable), sex, BMI (lineal and quadratic term), physical activity, alcohol consumption, sodium intake,
total energy intake, smoking (never, former, or current), and hypercholesterolemia (yes or no).
2 Cox regression model with additional adjustment for quintiles of fruit, vegetable, fiber, caffeine, magnesium, potassium, monosaturated fatty acid, and
saturated fatty acid intakes.
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was reported to be associated with a lower risk of type 2 diabetes
in a large cohort (32). Although diabetes is a different outcome,
both hypertension and diabetes share common risk factors and
are more frequently present in persons who have the metabolic
syndrome.
More recently, the WELL trial (a moderate-sodium, high-
potassium, high-calcium, low-fat DASH diet; 22) found that a
diet rich in low-fat dairy products resulted in a greater decrease
in BP than did a low-fat comparison diet, which supports the
beneficial effect of low-fat dairy consumption for the prevention
of hypertension. In fact, compared with the control group, the
only striking dietary changes in the intervention group were a
significant increase (1.5 servings/d) in the consumption of dairy
products and a significantly greater reduction in saturated fat
intake. This is likely explained because participants were offered
low-fat dairy products of their choice and were given specific
amounts for low-fat dairy consumption (22). This trial also found
a large difference between the 2 diets in the magnitude of the
effect, which is consistent with our results. Therefore, several
findings provide additional support for our results (22, 31, 32).
Even though the DASH Study has shown a beneficial effect of
a dietary pattern rich in low-fat dairy products, its design did not
allow the assessment of the separate effects of each component in
that diet. Moreover, assessment of the long-term effects of diet on
BP was not planned (2). Our results complement those of the
DASH trial because we showed how long-term consumption of
low-fat dairy products is inversely associated with the risk of
hypertension.
Our study has some important strengths. First, its prospective
design implies that information about diet and other risk factors
for hypertension was obtained before the diagnosis of the dis-
ease. All participants in the cohort were university graduates,
which suggests that the self-reported information was of good
quality, as was previously reported in other similar cohorts (33,
34). Furthermore, the dietary questionnaire used in the present
study was previously validated (14) and was used successfully in
another study by our group (35). With regard to the validity of
outcome ascertainment, abundant evidence indicates that self-
reported information about a hypertension diagnosis is valid for
epidemiologic studies (36), particularly in highly educated pop-
ulations (37). In a validation study that was conducted in a ran-
domly selected subsample of our cohort, we observed acceptable
positive and negative predictive values for self-reported medical
diagnoses of hypertension, even when our gold standard, which
was a repeated direct measurement, missed true cases of hyper-
tension. In addition, the results were the same when we included
only those participants who reported a BP measurement in the
period between both questionnaires in the analysis.
Cohort participants with higher low-fat dairy consumption
had a healthier lifestyle than did cohort participants with a lower
low-fat dairy consumption. Thus, residual confounding or some
unmeasured factor could explain the observed association, par-
ticularly if we consider that the strongest risk reduction was
evident for the participants in the highest quintile of low-fat dairy
consumption. These participants could be different from the rest
of the cohort. However, although we cannot rule out the existence
of unmeasured confounders, we adjusted our analyses for the
main important known risk factors for hypertension, including
alcohol use and other lifestyle variables such as smoking, which
could act as markers of a general healthier lifestyle. It is difficult
TABLE 4
Hazard ratios (HRs) and 95% CIs of hypertension according to quintiles of calcium intake in the Seguimiento Universidad de Navarra cohort
Quintile
P for trend1 2 3 4 5
Total calcium intake
New cases of hypertension 39 39 35 30 37
Person-years 2734.2 2725.5 2706.1 2668.2 2691.8
Incidence (cases per 1000 person-years) 14.3 14.3 12.9 11.2 13.7
Age- and sex-adjusted HR (95% CI) 1 0.94 (0.60, 1.47) 0.84 (0.53, 1.33) 0.78 (0.48, 1.26) 1.00 (0.63, 1.57) 0.85
Multivariate 1 HR (95% CI)1 1 0.98 (0.62, 1.54) 0.82 (0.51, 1.30) 0.73 (0.45, 1.19) 0.97 (0.61, 1.54) 0.67
Multivariate 2 HR (95% CI)2 1 0.99 (0.62, 1.59) 0.83 (0.51, 1.36) 0.69 (0.40, 1.18) 0.99 (0.57, 1.73) 0.71
Calcium from low-fat dairy products
New cases of hypertension 41 46 33 39 21
Person-years 2739.8 2709.8 2723.0 2651.7 2701.8
Incidence (cases per 1000 person-years) 15.0 17.0 12.1 14.7 7.8
Age- and sex-adjusted HR (95% CI) 1 0.95 (0.62, 1.46) 0.77 (0.49, 1.22) 0.95 (0.61, 1.48) 0.54 (0.32, 0.92) 0.03
Multivariate 1 HR (95% CI)1 1 0.76 (0.47, 1.24) 0.62 (0.38, 1.01) 0.74 (0.46, 1.20) 0.44 (0.25, 0.76) 0.007
Multivariate 2 HR (95% CI)2 1 0.77 (0.47, 1.26) 0.61 (0.37, 1.00) 0.76 (0.46, 1.26) 0.46 (0.25, 0.82) 0.02
Calcium from other dietary sources
New cases of hypertension 33 28 37 38 44
Person-years 2731.3 2707.8 2695.9 2700.1 2690.8
Incidence (cases per 1000 person-years) 12.1 10.3 13.7 14.1 16.4
Age- and sex-adjusted HR (95% CI) 1 0.85 (0.52, 1.41) 1.01 (0.63, 1.62) 1.06 (0.67, 1.69) 1.28 (0.81, 2.01) 0.15
Multivariate 1 HR (95% CI)1 1 0.81 (0.48, 1.36) 1.04 (0.64, 1.69) 1.10 (0.68, 1.76) 1.31 (0.83, 2.08) 0.10
Multivariate 2 HR (95% CI)2 1 0.82 (0.49, 1.39) 1.09 (0.65, 1.83) 1.11 (0.66, 1.87) 1.34 (0.77, 2.32) 0.16
1 Cox regression model adjusted for age (continuous variable), sex, BMI (lineal and quadratic term), physical activity, alcohol consumption, sodium intake,
total energy intake, smoking (never, former, or current), and hypercholesterolemia (yes or no).
2 Cox regression model with additional adjustment for quintiles of fruit, vegetable, fiber, caffeine, magnesium, potassium, monosaturated fatty acid, and
saturated fatty acid intakes.
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to think of an unknown risk factor that could produce a reduction
in risk such as we observed. Although we validated most of the
information in the questionnaires (14, 17, 19), sodium intake is
not easily measured with food-frequency questionnaires and
could partially explain the observed inverse association. We
acknowledge that adjustment for an imperfectly measured con-
founder could still lead to residual confounding. However, when
we adjusted for the relevant set of confounders, the estimates for
low-fat dairy products were away from the null value. If residual
confounding explained our results, then the expected change in
estimates after adjustment would be toward the null, not away
from the null. This shift in adjusted estimates can be explained by
a positive association between BMI and low-fat dairy product
consumption, which was not apparent in the crude analysis.
When we fitted a linear regression model with low-fat dairy
consumption as the outcome and age, sex, and BMI as predictors,
the coefficient for BMI was positive and showed a P value 
0.001. A similar positive relation was observed between hyper-
cholesterolemia and low-fat dairy product consumption (P 
0.001; see Table 2). That is, although low-fat dairy consumption
was associated with a healthier dietary pattern, important risk
factors for hypertension were also positively associated with
low-fat dairy consumption in our participants.
In conclusion, our results add new information about the role
of dairy products, especially those with a low-fat content, in the
prevention of hypertension. Particularly, we showed that the
possible beneficial effect of low-fat dairy consumption is not
restricted to young adults and obese persons. Additionally, our
study provided evidence to support a possible role of low-fat
dairy products in the primary prevention of hypertension, even in
a population with a high total fat intake.
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